These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7751656

  • 1. High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. Masking by IgG.
    Kozlowski PA, Black KP, Shen L, Jackson S.
    J Immunol; 1995 Jun 01; 154(11):6163-73. PubMed ID: 7751656
    [Abstract] [Full Text] [Related]

  • 2. Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons.
    Mazzoli S, Lopalco L, Salvi A, Trabattoni D, Lo Caputo S, Semplici F, Biasin M, Bl C, Cosma A, Pastori C, Meacci F, Mazzotta F, Villa ML, Siccardi AG, Clerici M.
    J Infect Dis; 1999 Sep 01; 180(3):871-5. PubMed ID: 10438383
    [Abstract] [Full Text] [Related]

  • 3. HIV-1 IgA specific serum antibodies and disease progression during HIV-1 infection.
    Margalith M, Levy E, Rinaldo CR, Detels R, Phair J, Kaslow R, Saah AJ, Sarov B.
    J Hum Virol; 2001 Sep 01; 4(5):269-77. PubMed ID: 11907384
    [Abstract] [Full Text] [Related]

  • 4. Predominate HIV1-specific IgG activity in various mucosal compartments of HIV1-infected individuals.
    Lü FX.
    Clin Immunol; 2000 Oct 01; 97(1):59-68. PubMed ID: 10998318
    [Abstract] [Full Text] [Related]

  • 5. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
    Moja P, Tranchat C, Tchou I, Pozzetto B, Lucht F, Desgranges C, Genin C.
    J Infect Dis; 2000 May 01; 181(5):1607-13. PubMed ID: 10823760
    [Abstract] [Full Text] [Related]

  • 6. Serum IgA-mediated neutralization of HIV type 1.
    Burnett PR, VanCott TC, Polonis VR, Redfield RR, Birx DL.
    J Immunol; 1994 May 01; 152(9):4642-8. PubMed ID: 8157978
    [Abstract] [Full Text] [Related]

  • 7. Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp120 V3 loop in HIV-infected individuals.
    Kozlowski PA, Chen D, Eldridge JH, Jackson S.
    AIDS Res Hum Retroviruses; 1994 Jul 01; 10(7):813-22. PubMed ID: 7986587
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1.
    Williams SB, Flanigan TP, Cu-Uvin S, Mayer K, Williams P, Ettore CA, Artenstein AW, Duerr A, VanCott TC.
    Clin Infect Dis; 2002 Sep 01; 35(5):611-7. PubMed ID: 12173138
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis of perinatally acquired HIV-1 infection using an IgA ELISA test.
    Liberatore D, Avila MM, Calarota S, Libonatti O, Martinez Peralta L.
    Pediatr AIDS HIV Infect; 1996 Jun 01; 7(3):164-7. PubMed ID: 11361583
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects.
    Raux M, Finkielsztejn L, Salmon-Céron D, Bouchez H, Excler JL, Dulioust E, Grouin JM, Sicard D, Blondeau C.
    AIDS Res Hum Retroviruses; 1999 Oct 10; 15(15):1365-76. PubMed ID: 10515152
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.